Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Farrell

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Gastroenterology Clinics of North America|April 17, 2012
Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopyGrace Chan, David S Fefferman, Richard J Farrell
Gastrointestinal Endoscopy Clinics of North America|February 28, 2004
New technology for endoscopic retrograde cholangiopancreatography: improving safety, success, and efficiencyRichard J Farrell, Douglas A Howell, Douglas K Pleskow
Gastrointestinal Endoscopy|October 25, 2002
Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary stricturesRichard J Farrell, Banke Agarwal, Steven L Brandwein, et al.
Radiology|May 31, 2003
Colorectal neoplasms: role of intravenous contrast-enhanced CT colonographyJacob Sosna, Martina M Morrin, Jonathan B Kruskal, et al.
Radiology|July 21, 2007
CT colonography in 546 patients with incomplete colonoscopyLaurian Copel, Jacob Sosna, Jonathan B Kruskal, et al.
Gastroenterology|April 3, 2003
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trialRichard J Farrell, Mazen Alsahli, Yoon-Tae Jeen, et al.
European Radiology|March 1, 2002
CT colonography: colonic distention improved by dual positioning but not intravenous glucagonMartina M Morrin, Richard J Farrell, Mary T Keogan, et al.
Inflammatory Bowel Diseases|October 12, 2004
Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's diseaseDavid S Fefferman, Parag J Lodhavia, Mazen Alsahli, et al.
Vaccine|May 27, 2008
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin AClaribel P Taylor, Sanjeev Tummala, Deborah Molrine, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 9, 2008
Parallel imaging enhanced MR colonography using a phantom modelMartina M Morrin, Ivan Pedrosa, Charles A McKenzie, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Gastroenterology Clinics of North America|April 17, 2012
Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopyGrace Chan, David S Fefferman, Richard J Farrell
Gastrointestinal Endoscopy Clinics of North America|February 28, 2004
New technology for endoscopic retrograde cholangiopancreatography: improving safety, success, and efficiencyRichard J Farrell, Douglas A Howell, Douglas K Pleskow
Gastrointestinal Endoscopy|October 25, 2002
Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary stricturesRichard J Farrell, Banke Agarwal, Steven L Brandwein, et al.
Radiology|May 31, 2003
Colorectal neoplasms: role of intravenous contrast-enhanced CT colonographyJacob Sosna, Martina M Morrin, Jonathan B Kruskal, et al.
Radiology|July 21, 2007
CT colonography in 546 patients with incomplete colonoscopyLaurian Copel, Jacob Sosna, Jonathan B Kruskal, et al.
Gastroenterology|April 3, 2003
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trialRichard J Farrell, Mazen Alsahli, Yoon-Tae Jeen, et al.
European Radiology|March 1, 2002
CT colonography: colonic distention improved by dual positioning but not intravenous glucagonMartina M Morrin, Richard J Farrell, Mary T Keogan, et al.
Inflammatory Bowel Diseases|October 12, 2004
Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's diseaseDavid S Fefferman, Parag J Lodhavia, Mazen Alsahli, et al.
Vaccine|May 27, 2008
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin AClaribel P Taylor, Sanjeev Tummala, Deborah Molrine, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 9, 2008
Parallel imaging enhanced MR colonography using a phantom modelMartina M Morrin, Ivan Pedrosa, Charles A McKenzie, et al.
Pageof 4